CNS Pharmaceuticals CNSP Income Statement (2018-2025)

NASDAQ CNSP
$6.00 +0.30 (+5.26%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter)
2.21M2.66M2.58M2.36M1.89M2.22M2.21M2.98M3.57M2.85M3.41M4.27M2.43M1.12M4.24M1.50M3.24M1.17M2.20M3.17M
Selling, General & Administrative (Quarter)
1.40M1.15M1.24M0.90M1.26M1.34M1.21M2.15M1.36M1.18M1.12M1.11M1.11M1.41M1.38M1.70M1.09M1.24M1.06M2.82M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
3.61M3.81M3.81M3.25M3.15M3.56M3.42M5.13M4.93M4.03M4.53M5.38M3.54M2.53M5.63M3.20M4.34M2.41M3.25M5.99M
Operating Income (Quarter)
-3.61M-3.81M-3.81M-3.25M-3.15M-3.56M-3.42M-5.13M-4.93M-4.03M-4.53M-5.38M-3.54M-2.53M-5.63M-3.20M-4.34M-2.41M-3.25M-5.99M
EBIT (Quarter)
-3.61M-3.81M-3.81M-3.25M-3.15M-3.56M-3.42M-5.13M-4.93M-4.03M-4.53M-5.38M-3.54M-2.53M-5.63M-3.20M-4.34M-2.41M-3.25M-5.99M
Non-operating items
Other Non Operating Income (Quarter)
0.01M0.01M0.01M0.01M0.00M0.03M0.03M0.04M0.04M0.04M0.04M
Non Operating Income (Quarter)
-0.00M-0.00M-947.00-0.00M-0.00M-0.00M-538.00-0.00M-0.01M0.00M0.01M0.00M106.00-0.00M0.02M0.02M0.04M0.03M0.03M0.03M
Net income details
EBT (Quarter)
-3.61M-3.81M-3.81M-3.25M-3.15M-3.57M-3.42M-5.14M-4.93M-4.07M-4.54M-5.38M-3.55M-2.53M-5.63M-3.20M-4.34M-2.41M-3.26M-5.99M
Profit After Tax (Quarter)
-3.61M-3.81M-3.81M-3.25M-3.15M-3.57M-3.42M-5.14M-4.93M-4.02M-4.52M-5.38M-3.54M-2.53M-5.61M-3.18M-4.30M-2.37M-3.22M-5.96M
Income from Continuing Operations (Quarter)
-3.61M-3.81M-3.81M-3.25M-3.15M-3.57M-3.42M-5.14M-4.93M-4.07M-4.54M-5.38M-3.55M-2.53M-5.63M-3.20M-4.34M-2.41M-3.26M-5.99M
Consolidated Net Income (Quarter)
-3.61M-3.81M-3.81M-3.25M-3.15M-3.57M-3.42M-5.14M-4.93M-4.07M-4.54M-5.38M-3.55M-2.53M-5.63M-3.20M-4.34M-2.41M-3.26M-5.99M
Income towards Parent Company (Quarter)
-3.61M-3.81M-3.81M-3.25M-3.15M-3.57M-3.42M-5.14M-4.93M-4.07M-4.54M-5.38M-3.55M-2.53M-5.63M-3.20M-4.34M-2.41M-3.26M-5.99M
Net Income towards Common Stockholders (Quarter)
-3.61M-3.81M-3.81M-3.25M-3.15M-3.57M-3.42M-5.14M-4.93M-4.07M-4.54M-5.38M-3.55M-2.53M-5.63M-3.20M-4.34M-2.41M-3.26M-5.99M
Additional items
EPS (Basic) (Quarter)
-0.13M-0.14M-0.13M-0.11M-0.07M-0.08M-0.08M-0.11M-0.08M-0.03M-0.03M-0.04M-0.01M-0.00M-152.33-100.47-19.12-6.52-5.83-13.51
EPS (Diluted) (Quarter)
-0.14M-0.13M-0.11M-0.07M-0.08M-0.08M-0.11M-0.08M-0.03M-0.03M-0.04M-0.01M-0.00M-152.33-100.47-19.12-6.52-5.83-13.51
Shares Outstanding (Quarter)
27.0028.0030.0029.0043.0044.0044.0045.0064.00129.00139.00126.00290.00628.000.04M0.03M0.23M0.37M0.56M0.44M
Shares Outstanding (Diluted) (Quarter)
28.0030.0029.0043.0044.0044.0045.0064.00129.00139.00126.00290.00628.000.04M0.03M0.23M0.37M0.56M0.44M
Shares Outstanding (Entity) (Quarter)
28.0030.0031.0031.0044.0044.0044.0054.0074.00138.00140.00126.00290.00628.000.04M0.03M0.25M0.37M0.57M0.44M
EBITDA (Quarter)
-3.61M-3.81M-3.81M-3.25M-3.15M-3.56M-3.42M-5.13M-4.93M-4.03M-4.53M-5.38M-3.54M-2.53M-5.63M-3.20M-4.34M-2.41M-3.25M-5.99M
Interest Expenses (Quarter)
0.00M0.00M947.000.00M0.00M0.00M538.000.00M0.01M0.05M0.00M0.00M0.01M0.00M0.00M253.000.01M0.00M0.00M0.00M